MA46897A - Insuline dégludec utilisée dans des conditions cardiovasculaires - Google Patents

Insuline dégludec utilisée dans des conditions cardiovasculaires

Info

Publication number
MA46897A
MA46897A MA046897A MA46897A MA46897A MA 46897 A MA46897 A MA 46897A MA 046897 A MA046897 A MA 046897A MA 46897 A MA46897 A MA 46897A MA 46897 A MA46897 A MA 46897A
Authority
MA
Morocco
Prior art keywords
cardiovascular conditions
insulin degludec
degludec
insulin
cardiovascular
Prior art date
Application number
MA046897A
Other languages
English (en)
French (fr)
Inventor
Kajsa Kvist
Simon Skibsted
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MA46897A publication Critical patent/MA46897A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA046897A 2016-11-28 2017-11-28 Insuline dégludec utilisée dans des conditions cardiovasculaires MA46897A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16200906 2016-11-28
EP17174682 2017-06-07

Publications (1)

Publication Number Publication Date
MA46897A true MA46897A (fr) 2021-04-28

Family

ID=60937677

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046897A MA46897A (fr) 2016-11-28 2017-11-28 Insuline dégludec utilisée dans des conditions cardiovasculaires

Country Status (6)

Country Link
US (2) US11278596B2 (enExample)
EP (1) EP3544683A1 (enExample)
JP (1) JP7193455B2 (enExample)
CN (1) CN110022935A (enExample)
MA (1) MA46897A (enExample)
WO (1) WO2018096162A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110022935A (zh) 2016-11-28 2019-07-16 诺和诺德股份有限公司 用于心血管病况的德谷胰岛素
TWI797133B (zh) 2017-06-09 2023-04-01 丹麥商諾佛 儂迪克股份有限公司 用於經口投予的固體組成物
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
JP7518149B2 (ja) 2019-07-12 2024-07-17 ノヴォ ノルディスク アー／エス 高濃度インスリン製剤
CN113773397B (zh) * 2020-06-10 2023-10-20 宁波鲲鹏生物科技有限公司 一种德谷胰岛素的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2283025T3 (es) 1996-08-30 2007-10-16 Novo Nordisk A/S Derivados de glp-1.1.
GB0309154D0 (en) * 2003-01-14 2003-05-28 Aventis Pharma Inc Use of insulin glargine to reduce or prevent cardiovascular events in patients being treated for dysglycemia
BRPI0413276B8 (pt) 2003-08-05 2021-05-25 Novo Nordisk As derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica
HK1201155A1 (en) * 2012-03-28 2015-08-28 Sanofi-Aventis Deutschland Gmbh Basal insulin therapy
WO2014147141A1 (en) 2013-03-20 2014-09-25 Novo Nordisk A/S Insulin dosing regimen
WO2014177623A1 (en) * 2013-04-30 2014-11-06 Novo Nordisk A/S Novel administration regime
WO2018096163A1 (en) 2016-11-28 2018-05-31 Novo Nordisk A/S Insulin degludec for improvement of glycaemic control and reduction of acute and long-term diabetes complications
CN110022935A (zh) 2016-11-28 2019-07-16 诺和诺德股份有限公司 用于心血管病况的德谷胰岛素

Also Published As

Publication number Publication date
CN110022935A (zh) 2019-07-16
JP2019535785A (ja) 2019-12-12
JP7193455B2 (ja) 2022-12-20
WO2018096162A1 (en) 2018-05-31
US20190374614A1 (en) 2019-12-12
US12233114B2 (en) 2025-02-25
EP3544683A1 (en) 2019-10-02
US20220160840A1 (en) 2022-05-26
US11278596B2 (en) 2022-03-22

Similar Documents

Publication Publication Date Title
IL256999B (en) Diabetes management therapy advisor
EP3283587C0 (en) CROSS-LINKABLE RMA RESIN AND USE IN CROSS-LINKABLE RMA COMPOSITIONS
EP3305519A4 (en) METAL RESIN COMPLEX
EP3360283C0 (en) Distributed transactions with token-associated execution
MA41188A (fr) Compositions d'insuline à action rapide
DK2963056T3 (da) Insulinanalog og anvendelse deraf
DK3368085T3 (da) Modificerede alginater til anti-fibrotiske materialer og anvendelser
EP3227425C0 (en) LIQUID CLEANING COMPOSITIONS COMPRISING PROTEASE VARIANTS
DK3120239T3 (da) Fælles bootsekvens til styringsmodul der kan initialiseres i flere arkitekturer
DK3536380T3 (da) Hurtigtvirkende insulinsammensætninger
DK3152607T3 (da) En antiresonant hulkernefiber
HRP20190369T1 (hr) Spojevi dihidrobenzofurana koji su korisni u liječenju dijabetesa i pretilosti
EP3314445A4 (en) COHERENT FABRIC CONNECTION FOR USE IN SEVERAL TOPOLOGIES
IL256939B (en) Rapid-acting insulin compositions
FR3024271B1 (fr) Plusieurs tailles de mots codes ecc dans un ssd
MA46897A (fr) Insuline dégludec utilisée dans des conditions cardiovasculaires
DK3229828T5 (da) Formulering med fast forhold mellem insulin glargin og lixisenatid
DK2959455T3 (da) Forbedringer af eller relaterende til billedbehandling
EP3371825A4 (en) COMPOSITIONS COMPRISING MATRIX AND CAPSULE MATERIALS FOR USE IN ELECTRONIC DEVICES
EP3380616A4 (en) MANUFACTURE OF VIRUSES IN BIRDS
HUE055728T2 (hu) Posztbariatrikus hipoglikémia kezelése exendin(9-39)-el
EP3444327C0 (en) Dishwashing tablets
EP3307306A4 (en) GENE EXPRESSION IN BACTEROIDES
DK3209677T3 (da) Varianter af gal2-transporter og anvendelser deraf
DK3324937T3 (da) Brugsfærdig bortezomib-opløsning